EL
37
3
HCP
31
-5
ED
56
11
AN
41
-2
DG
42
5
ROP
50
3
PWR
67
2
XRAY
37
17
RRC
52
4
FE
57
4
PVH
33
-5
AAPL
56
3
K
50
6
PGR
63
6
GILD
65
2
RHI
33
3
MO
57
4
QRVO
33
-3
ADSK
50
-6
KEY
12
2
EL
37
3
HCP
31
-5
ED
56
11
AN
41
-2
DG
42
5
ROP
50
3
PWR
67
2
XRAY
37
17
RRC
52
4
FE
57
4
PVH
33
-5
AAPL
56
3
K
50
6
PGR
63
6
GILD
65
2
RHI
33
3
MO
57
4
QRVO
33
-3
ADSK
50
-6
KEY
12
2
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

20-cent Gold Stock Has Backing of Major Gold Producers

The time to get in is now BEFORE next drill results are released.
Buy
53

VYGR
Voyager Therapeutics

Last Price:
7.26
Seasonality Move:
16.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Make The SMART Move and Get The Inflation Survival Plan!

So don't wait until it's too late, act now and secure your future TODAY!

Voyager Therapeutics Price Quote

$7.26
-0.11 (-1.49%)
(Updated: March 27, 2023 at 10:10 PM ET)

Voyager Therapeutics Key Stats

Buy
53
Voyager Therapeutics (VYGR) is a Buy
Day range:
$7.11 - $7.44
52-week range:
$4.61 - $10.82
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.96
P/B ratio:
5.41%
Volume:
227K
Avg. volume:
314.8K
1-year change:
-21.85%
Market cap:
$319.1M
Revenue:
$40.9M
EPS:
$-1.22

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

Data Unavailable

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.5M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.1M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.3M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is -62.73%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -24.47%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is -62.73%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Data Unavailable

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -21.19%
Revenue: 0% -141.54%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 10.17
Upside from Last Price: 37.95%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    37.7M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    2.5M VYGR shares are owned by insiders